ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,788Medicare Part D Prescriptions Filled, Including Refills

Rank: 17 out of 198

$847K Total Retail Price of All Prescriptions

Rank: 15 out of 198

601 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 601 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

25% of this provider’s 601 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 10,559 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
HYDROCODONE-ACETAMINOPHEN 724 408 S3 1 8
LEVOTHYROXINE SODIUM 639 491 2 1
OMEPRAZOLE 529 364 3 3
WARFARIN SODIUM 517 447 4 7
FUROSEMIDE 499 361 5 5
LISINOPRIL 414 307 6 6
SIMVASTATIN 382 237 7 2
GABAPENTIN 378 253 8 14
AMLODIPINE BESYLATE 342 304 9 4
POTASSIUM CHLORIDE 258 174 10 9
METFORMIN HCL 232 153 11 13
TRAMADOL HCL 207 139 12 15
HYDROCHLOROTHIAZIDE 177 101 13 16
ZOLPIDEM TARTRATE 174 78 14 22
DONEPEZIL HCL 162 162 15 28
POLYETHYLENE GLYCOL 3350 154 141 16 41
METOPROLOL SUCCINATE 153 109 17 11
METOPROLOL TARTRATE 150 129 18 10
SERTRALINE HCL 148 111 19 25
FENOFIBRATE 144 61 20 61
ALENDRONATE SODIUM 135 132 21 21
PAROXETINE HCL 125 79 22 65
NAMENDA 124 123 23 33
CARVEDILOL 120 96 24 24
OXYCODONE HCL-ACETAMINOPHEN 118 25 S2 25 220
FENTANYL 116 58 S2 26 73
CITALOPRAM HBR 111 69 27 20
ROPINIROLE HCL 107 76 28 74
GLIMEPIRIDE 105 80 29 35
LISINOPRIL-HYDROCHLOROTHIAZIDE 105 63 29 38
CYCLOBENZAPRINE HCL 104 32 R 31 67
ATENOLOL 102 65 32 17
CYMBALTA 100 47 33 48
NEXIUM 98 43 34 40
PRAVASTATIN SODIUM 97 55 35 19
FAMOTIDINE 94 82 36 57
TRAZODONE HCL 93 58 37 50
PREDNISONE 92 75 38 29
GLIPIZIDE 91 61 39 62
PANTOPRAZOLE SODIUM 91 45 39 31
ADVAIR DISKUS 88 65 41 47
OXYCODONE-ACETAMINOPHEN 88 35 S2 41 79
TAMSULOSIN HCL 85 78 43 27
MORPHINE SULFATE ER 84 33 S2 44 160
LEVOFLOXACIN 82 67 45 81
CEPHALEXIN 82 60 45 108
ESCITALOPRAM OXALATE 81 73 47 53
MELOXICAM 80 56 48 30
LOVAZA 80 41 48 215
BYSTOLIC 80 79 48 58
LOSARTAN POTASSIUM 79 55 51 18
AZITHROMYCIN 79 40 51 56
SPIRONOLACTONE 78 68 53 37
ESTRADIOL 78 23 R 53 172
MIRTAZAPINE 76 70 55 44
SPIRIVA 75 50 56 63
DIOVAN 73 57 57 34
SYNTHROID 69 48 58 36
OXYCONTIN 68 0 S2 59 151
LANTUS 67 45 60 46
SINGULAIR 67 33 60 106
FLUTICASONE PROPIONATE 65 44 62 39
ENDOCET 64 0 S2 63 218
ISOSORBIDE MONONITRATE ER 63 60 64 60
PROMETHAZINE HCL 62 35 R 65 260
NYSTOP 61 56 66 189
AMITRIPTYLINE HCL 60 43 R 67 69
FLUOXETINE HCL 60 45 67 78
CARBIDOPA-LEVODOPA 60 60 67 71
TRICOR 59 0 70 93
ATORVASTATIN CALCIUM 59 32 70 12
CARISOPRODOL 58 0 R 72 198
PROAIR HFA 58 20 72 80
VESICARE 57 38 74 77
FLUCONAZOLE 55 26 75 193
CRESTOR 54 47 76 26
TRIAMTERENE-HCTZ 54 53 76 32
RANITIDINE HCL 54 16 76 54
METFORMIN HCL ER 52 30 79 64
HUMALOG 51 45 80 128
IPRATROPIUM-ALBUTEROL 51 49 80 180
DOXEPIN HCL 50 35 82 217
DIVALPROEX SODIUM ER 50 17 82 186
ALLOPURINOL 50 33 82 23
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 13, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.